Anzeige
Mehr »
Donnerstag, 11.09.2025 - Börsentäglich über 12.000 News
BREAKING NEWS: CiTech unterzeichnet Exklusivvertrag mit Babcock - Ukraine-Deal katapultiert Aktie in neue Liga
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A412AD | ISIN: US83006G4010 | Ticker-Symbol:
NASDAQ
10.09.25 | 18:23
1,410 US-Dollar
+0,71 % +0,010
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
60 DEGREES PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
60 DEGREES PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur 60 DEGREES PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
60 DEGREES PHARMACEUTICALS Aktie jetzt für 0€ handeln
Fr60 DEGREES PHARMACEUTICALS, INC. - 8-K, Current Report1
19.08.60 Degrees Pharma to begin trial of tafenoquine for chronic babesiosis2
19.08.60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis6
13.08.60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results82A now resolved supply disruption led to Q2 net product revenue decline but higher profitability due to increased usage of a cash-pay distribution model$1.97 million cash on hand, runway through March...
► Artikel lesen
13.08.60 DEGREES PHARMACEUTICALS, INC. - 10-Q, Quarterly Report1
08.08.RedChip Companies, Inc.: Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV338ORLANDO, FLORIDA / ACCESS Newswire / August 8, 2025 / RedChip Companies will air interviews with Aptevo Therapeutics, Inc. (NASDAQ:APVO) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip...
► Artikel lesen
18.07.60 DEGREES PHARMACEUTICALS, INC. - 8-K, Current Report-
17.07.60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria3
16.07.60 Degrees Pharmaceuticals closes $5 million public offering3
16.07.60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering5
15.07.60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering3
15.07.60 Degrees Pharma targets $245 million market for babesiosis treatment1
15.07.60 Degrees Pharmaceuticals Defines Potential Human Babesiosis Market Size for ARAKODA (tafenoquine): Annual Max TAM, Sales of $245 Million; Cumulative through Patent Expiration, $1.1 Billion236New Drug Application intended for 2026, subject to generation of positive data from three U.S. clinical trials planned or in progressTotal addressable market (TAM) for ARAKODA for Human Babesiosis...
► Artikel lesen
14.07.Pläne für Tierarzneimittel treiben Aktie von 60 Degrees Pharmaceuticals an3
14.07.60 Degrees Pharmaceuticals stock surges on canine babesiosis treatment plans1
14.07.60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025282Data from three independent clinical studies demonstrate utility of tafenoquine to treat acute canine babesiosis WASHINGTON, July 14, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ:...
► Artikel lesen
07.07.60 DEGREES PHARMACEUTICALS, INC. - S-1, General form for registration of securities2
06.06.RedChip Companies, Inc.: 60 Degrees Pharmaceuticals and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV578ORLANDO, FL / ACCESS Newswire / June 6, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and Liberty Star Minerals (OTCQB:LBSR) on the RedChip Small Stocks...
► Artikel lesen
04.06.60 Degrees Pharmaceuticals introduces new malaria drug packaging1
04.06.60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA (tafenoquine) 8-Count Bottle Format129New 8-count bottles now available through major retail pharmaciesARAKODA® is the only weekly prophylactic therapy to provide protection against the blood and liver stages of malaria WASHINGTON, June...
► Artikel lesen
Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1